BA Neuschwander-Tetri, SH Caldwell - Hepatology, 2003 - ualberta.ca Fatty liver disease that develops in the absence of alcohol abuse is recognized
increasingly as a major health burden. This report summarizes the presentations
and discussions at a Single Topic Conference held September 20-22, 2002, ... Cited by 828 - Related articles - View as HTML - BL Direct - All 9 versions
- ►endojournals.org FCW Wu, A von Eckardstein - Endocrine Reviews, 2003 - Endocrine Soc A significant and independent association between endogenous testosterone (T)
levels and coronary events in men and women has not been confirmed in large
prospective studies, although cross-sectional data have suggested coronary ... Cited by 266 - Related articles - BL Direct - All 8 versions
CJ Glueck, H Phillips, D Cameron, L Sieve- … - Fertility and sterility, 2001 - Elsevier Objective: To determine whether metformin would safely reduce the rate of
first-trimester spontaneous abortion without teratogenicity in 19 women with the
polycystic ovary syndrome (PCOS). ... Patient(s): Twenty-two previously ... Cited by 262 - Related articles - BL Direct - All 10 versions
CJ Glueck, P Wang, S Kobayashi, H Phillips, … - Fertility and sterility, 2002 - Elsevier Patient(s): The prospective study included 33 nondiabetic women with PCOS who
conceived while taking metformin and had live births; of these, 28 were taking
metformin through delivery. The retrospective study included 39 nondiabetic ... Cited by 224 - Related articles - BL Direct - All 11 versions
CJ Glueck, R Papanna, P Wang, N Goldenberg … - Metabolism, 2003 - Elsevier In 138 oligo-amenorrheic white women with polycystic ovary syndrome (PCOS) (31
± 9-years-old), our first specific aim was to assess the incidence of the
metabolic syndrome and to compare metabolic syndrome abnormalities in women ... Cited by 189 - Related articles - All 12 versions
- ►endojournals.org N Brettenthaler, C De Geyter, PR Huber, U … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, chronic
anovulation, and insulin resistance; long-term consequences include diabetes
mellitus type 2. The aim of this randomized, double-blind, controlled trial ... Cited by 145 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org PWF Wilson, SM Grundy - Circulation, 2003 - Am Heart Assoc Background It is appropriate to consider jointly the effects of low HDL
cholesterol (HDL-C) and high triglyceride levels as components of the metabolic
syndrome (MetS). In observational studies, each of these factors is related ... Cited by 142 - Related articles - BL Direct - All 9 versions
- ►endojournals.org F Orio Jr, S Palomba, L Spinelli, T Cascella, … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc To evaluate the cardiovascular risk of polycystic ovary syndrome (PCOS), we
investigated lipid profile, metabolic pattern, and echocardiography in 30 young
women with PCOS and 30 healthy age- and body mass index (BMI)-matched ... Cited by 140 - Related articles - BL Direct - All 5 versions
- ►endojournals.org F Orio Jr, S Palomba, T Cascella, B De Simone … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Thirty young normal-weight women with PCOS, who had no additional metabolic or
cardiovascular diseases, and 30 healthy women (controls) matched for age and
body mass index were studied. A complete hormonal assay was performed in ... Cited by 126 - Related articles - BL Direct - All 5 versions
RJ Norman, MJ Davies, J Lord, LJ Moran - Trends in Endocrinology & Metabolism, 2002 - Elsevier Polycystic ovary syndrome (PCOS) is a common endocrine condition with
reproductive and metabolic consequences, including anovulation, infertility and
an increased prevalence of diabetes mellitus. Obesity, central obesity and ... Cited by 122 - Related articles - All 7 versions
